Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 0.10
PDCO's Cash-to-Debt is ranked lower than
86% of the 59 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.69 vs. PDCO: 0.10 )
Ranked among companies with meaningful Cash-to-Debt only.
PDCO' s Cash-to-Debt Range Over the Past 10 Years
Min: -0.57  Med: 0.7 Max: No Debt
Current: 0.1
-0.57
No Debt
Equity-to-Asset 0.40
PDCO's Equity-to-Asset is ranked lower than
57% of the 58 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.44 vs. PDCO: 0.40 )
Ranked among companies with meaningful Equity-to-Asset only.
PDCO' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.03  Med: 0.59 Max: 0.78
Current: 0.4
0.03
0.78
Debt-to-Equity 0.81
PDCO's Debt-to-Equity is ranked lower than
65% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.56 vs. PDCO: 0.81 )
Ranked among companies with meaningful Debt-to-Equity only.
PDCO' s Debt-to-Equity Range Over the Past 10 Years
Min: 0  Med: 0.36 Max: 9.82
Current: 0.81
0
9.82
Debt-to-EBITDA 3.26
PDCO's Debt-to-EBITDA is ranked lower than
64% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.37 vs. PDCO: 3.26 )
Ranked among companies with meaningful Debt-to-EBITDA only.
PDCO' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 1.24  Med: 1.92 Max: 2.84
Current: 3.26
1.24
2.84
Interest Coverage 5.99
PDCO's Interest Coverage is ranked lower than
69% of the 51 Companies
in the Global Medical Distribution industry.

( Industry Median: 12.71 vs. PDCO: 5.99 )
Ranked among companies with meaningful Interest Coverage only.
PDCO' s Interest Coverage Range Over the Past 10 Years
Min: 6.69  Med: 10.61 Max: 28.08
Current: 5.99
6.69
28.08
Piotroski F-Score: 5
Altman Z-Score: 3.18
Beneish M-Score: -2.38
WACC vs ROIC
7.26%
11.80%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 4.99
PDCO's Operating Margin % is ranked higher than
59% of the 59 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.60 vs. PDCO: 4.99 )
Ranked among companies with meaningful Operating Margin % only.
PDCO' s Operating Margin % Range Over the Past 10 Years
Min: 5.15  Med: 9.94 Max: 11.98
Current: 4.99
5.15
11.98
Net Margin % 4.39
PDCO's Net Margin % is ranked higher than
66% of the 59 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.61 vs. PDCO: 4.39 )
Ranked among companies with meaningful Net Margin % only.
PDCO' s Net Margin % Range Over the Past 10 Years
Min: 3.06  Med: 5.9 Max: 7.5
Current: 4.39
3.06
7.5
ROE % 17.28
PDCO's ROE % is ranked higher than
83% of the 59 Companies
in the Global Medical Distribution industry.

( Industry Median: 9.39 vs. PDCO: 17.28 )
Ranked among companies with meaningful ROE % only.
PDCO' s ROE % Range Over the Past 10 Years
Min: 12.05  Med: 14.99 Max: 18.86
Current: 17.28
12.05
18.86
ROA % 6.79
PDCO's ROA % is ranked higher than
83% of the 59 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.37 vs. PDCO: 6.79 )
Ranked among companies with meaningful ROA % only.
PDCO' s ROA % Range Over the Past 10 Years
Min: 4.86  Med: 7.89 Max: 11.2
Current: 6.79
4.86
11.2
ROC (Joel Greenblatt) % 26.09
PDCO's ROC (Joel Greenblatt) % is ranked lower than
52% of the 58 Companies
in the Global Medical Distribution industry.

( Industry Median: 22.92 vs. PDCO: 26.09 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
PDCO' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 25.7  Med: 57.34 Max: 106.61
Current: 26.09
25.7
106.61
3-Year Revenue Growth Rate 18.40
PDCO's 3-Year Revenue Growth Rate is ranked higher than
81% of the 47 Companies
in the Global Medical Distribution industry.

( Industry Median: 9.70 vs. PDCO: 18.40 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
PDCO' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 6.9  Med: 12.85 Max: 27.6
Current: 18.4
6.9
27.6
3-Year EBITDA Growth Rate 5.80
PDCO's 3-Year EBITDA Growth Rate is ranked lower than
68% of the 41 Companies
in the Global Medical Distribution industry.

( Industry Median: 8.60 vs. PDCO: 5.80 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
PDCO' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -2  Med: 17.2 Max: 46.9
Current: 5.8
-2
46.9
3-Year EPS without NRI Growth Rate 2.50
PDCO's 3-Year EPS without NRI Growth Rate is ranked lower than
70% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 6.10 vs. PDCO: 2.50 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
PDCO' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -3.7  Med: 17.9 Max: 43
Current: 2.5
-3.7
43
GuruFocus has detected 5 Warning Signs with Patterson Companies Inc PDCO.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» PDCO's 30-Y Financials

Financials (Next Earnings Date: 2018-05-25)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q2 2017

PDCO Guru Trades in Q2 2017

Steven Cohen 412,400 sh (New)
Ken Fisher 86,482 sh (New)
Joel Greenblatt 215,203 sh (New)
Jerome Dodson 777,000 sh (+18.70%)
Barrow, Hanley, Mewhinney & Strauss 3,342,010 sh (+17.86%)
Tom Gayner 168,000 sh (unchged)
Chuck Royce 15,000 sh (unchged)
Mairs and Power 2,327,065 sh (unchged)
Third Avenue Management 81,500 sh (unchged)
First Pacific Advisors 26,050 sh (unchged)
Mario Gabelli 1,276,182 sh (-3.89%)
Robert Olstein 260,750 sh (-26.05%)
» More
Q3 2017

PDCO Guru Trades in Q3 2017

Third Avenue Management 131,100 sh (+60.86%)
Barrow, Hanley, Mewhinney & Strauss 4,878,432 sh (+45.97%)
Ken Fisher 125,300 sh (+44.89%)
Steven Cohen 574,200 sh (+39.23%)
Robert Olstein 329,020 sh (+26.18%)
Mario Gabelli 1,421,850 sh (+11.41%)
Jerome Dodson 856,000 sh (+10.17%)
Mairs and Power 2,335,095 sh (+0.35%)
Tom Gayner 168,000 sh (unchged)
Steven Cohen 200,000 sh (unchged)
First Pacific Advisors Sold Out
Chuck Royce 14,329 sh (-4.47%)
Joel Greenblatt 122,317 sh (-43.16%)
» More
Q4 2017

PDCO Guru Trades in Q4 2017

Paul Tudor Jones 23,807 sh (New)
Charles Brandes 60,949 sh (New)
Pioneer Investments 2,620 sh (New)
Barrow, Hanley, Mewhinney & Strauss 5,182,834 sh (+6.24%)
Steven Cohen 200,000 sh (unchged)
Jerome Dodson 856,000 sh (unchged)
Tom Gayner 168,000 sh (unchged)
Ken Fisher 125,300 sh (unchged)
Third Avenue Management Sold Out
Robert Olstein 327,088 sh (-0.59%)
Chuck Royce 13,837 sh (-3.43%)
Joel Greenblatt 116,605 sh (-4.67%)
Mario Gabelli 1,333,883 sh (-6.19%)
Mairs and Power 2,068,212 sh (-11.43%)
Steven Cohen 206,650 sh (-64.01%)
» More
Q1 2018

PDCO Guru Trades in Q1 2018

Jerome Dodson 856,000 sh (unchged)
» More
» Details

Insider Trades

Latest Guru Trades with PDCO

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Barrow, Hanley, Mewhinney & Strauss 2017-12-31 Add 6.24%0.02%$33.38 - $39.86 $ 22.33-39%5,182,834
Mario Gabelli 2017-12-31 Reduce -6.19%0.02%$33.38 - $39.86 $ 22.33-39%1,333,883
Robert Olstein 2017-12-31 Reduce -0.59%0.01%$33.38 - $39.86 $ 22.33-39%327,088
Joel Greenblatt 2017-12-31 Reduce -4.67%$33.38 - $39.86 $ 22.33-39%116,605
Charles Brandes 2017-12-31 New Buy0.04%$33.38 - $39.86 $ 22.33-39%60,949
Third Avenue Management 2017-12-31 Sold Out 0.23%$33.38 - $39.86 $ 22.33-39%0
Barrow, Hanley, Mewhinney & Strauss 2017-09-30 Add 45.97%0.09%$36.27 - $47.51 $ 22.33-44%4,878,432
Mario Gabelli 2017-09-30 Add 11.41%0.03%$36.27 - $47.51 $ 22.33-44%1,421,850
Robert Olstein 2017-09-30 Add 26.18%0.34%$36.27 - $47.51 $ 22.33-44%329,020
Third Avenue Management 2017-09-30 Add 60.86%0.09%$36.27 - $47.51 $ 22.33-44%131,100
Ken Fisher 2017-09-30 Add 44.89%$36.27 - $47.51 $ 22.33-44%125,300
Joel Greenblatt 2017-09-30 Reduce -43.16%0.06%$36.27 - $47.51 $ 22.33-44%122,317
Barrow, Hanley, Mewhinney & Strauss 2017-06-30 Add 17.86%0.04%$42.51 - $47.93 $ 22.33-50%3,342,010
Mario Gabelli 2017-06-30 Reduce -3.89%0.01%$42.51 - $47.93 $ 22.33-50%1,276,182
Robert Olstein 2017-06-30 Reduce -26.05%0.53%$42.51 - $47.93 $ 22.33-50%260,750
Joel Greenblatt 2017-06-30 New Buy0.14%$42.51 - $47.93 $ 22.33-50%215,203
Ken Fisher 2017-06-30 New Buy0.01%$42.51 - $47.93 $ 22.33-50%86,482
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Distribution » Medical Distribution    NAICS: 423450    SIC: 5047
Compare:SHSE:600763, NZSE:EBO, NYSE:PBH, SHSE:600090, LSE:CLIN, SHSE:603368, TSE:7476, LSE:UDG, NYSE:OMI, SZSE:002551, SZSE:002589, ASX:SIG, ASX:API, SZSE:200028, TSE:3183, ISX:EPMT, XPAR:BLC, SHSE:600056, CAI:IBNP.CA, HKSE:01011 » details
Traded in other countries:PD2.Germany,
Headquarter Location:USA
Patterson Companies Inc is a value-added specialty distributor. It operates through its two strategic business units, Patterson Dental and Patterson Animal Health, offering similar products and services to different customer bases.

Patterson is one of the largest distributors and wholesalers of dental and animal health products, equipment, and devices in the United States. Patterson offers dental practice management products, including office software products, technical, financial, and educational services, to thousands of dental practices throughout North America. It also is a major supplier of animal health products to vets and production companies in the United Kingdom.

Guru Investment Theses on Patterson Companies Inc

Jerome Dodson Comments on Patterson Companies - Feb 13, 2018

Patterson Companies (NASDAQ:PDCO), a leading animal health and dental distributor, sank 11.9% from $41.03 to $36.13, lowering the Fund’s return by 34 basis points. The company reported weak earnings due to sluggish dental sales caused by personnel issues and the loss of exclusivity with its largest dental manufacturing partner. The stock is now on the bargain table, and we’re hopeful the newly appointed CEO, Mark Walchirk, will improve Patterson’s sales execution and operating margins.

From Jerome Dodson (Trades, Portfolio)'s fourth-quarter 2017 Parnassus Fund shareholder letter.

Check out Jerome Dodson latest stock trades

Jerome Dodson Comments on Patterson Companies - Oct 25, 2017

Patterson Companies (NASDAQ:PDCO), a leading animal health and dental distributor, sank 17.7% from $46.95 to $38.65, cutting 60 basis points from the Fund’s return. The stock declined after the company delivered disappointing sales results, driven primarily by poor execution and the loss of exclusivity with its largest dental manufacturing partner. Turnover in the dental sales force and the ongoing uncertainty around the CEO search process further weighed on the stock. We’re holding onto our shares because we believe there are multiple ways to win going forward. The company operates in two disparate businesses, and we believe value could be unlocked if the company divests the animal health business and reinvests in the high-margin dental business. We also believe there is a significant opportunity to improve the company’s earnings power by reducing costs and increasing private-label penetration. With the stock’s valuation at a multi-year low, we think our upside is significant.


From Jerome Dodson (Trades, Portfolio)'s Parnassus Fund third quarter 2017 commentary.

Check out Jerome Dodson latest stock trades

Jerome Dodson Comments on Patterson Companies - Apr 26, 2017

Patterson Companies (NASDAQ:PDCO), a leading dental and animal health distributor, climbed 10.2% from $41.03 to $45.23, adding 31 basis points to the Fund’s return. The stock rose after the company delivered better-than-expected earnings, driven by solid results in its companion animal distribution business. The stock moved higher again after several competitors indicated that demand for dental consumables is improving.

Jerome Dodson (Trades, Portfolio)'s first quarter 2017 Parnassus Funds commentary.

Check out Jerome Dodson latest stock trades

Top Ranked Articles about Patterson Companies Inc

PDCO ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Patterson Companies, Inc. – PDCO
The Klein Law Firm Announces a Class Action Filed on Behalf of Patterson Companies, Inc. Shareholders and a Lead Plaintiff Deadline of May 29, 2018 (PDCO)
PATTERSON COMPANIES SHAREHOLDER ALERT: CLAIMSFILER Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Patterson Companies, Inc. - PDCO
PDCO SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Patterson Companies, Inc. and a Lead Plaintiff Deadline of May 29, 2018
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Patterson Companies, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 29, 2018 – PDCO
Hagens Berman Alerts Investors in Patterson Companies to the May 29, 2018 Lead Plaintiff Deadline in the Pending Securities Class Action
RM LAW Announces Class Action Lawsuit Against Patterson Companies, Inc.
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Patterson Companies, Inc. (PDCO) and Lead Plaintiff Deadline: May 29, 2018
SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Patterson Companies, Inc. (Nasdaq: PDCO) To Contact Brower Piven Before The Lead Plaintiff Deadline
PATTERSON COMPANIES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Patterson Companies, Inc. - PDCO

Ratios

vs
industry
vs
history
PE Ratio 8.62
PDCO's PE Ratio is ranked higher than
92% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 19.00 vs. PDCO: 8.62 )
Ranked among companies with meaningful PE Ratio only.
PDCO' s PE Ratio Range Over the Past 10 Years
Min: 8.44  Med: 19.2 Max: 26.73
Current: 8.62
8.44
26.73
Forward PE Ratio 11.05
PDCO's Forward PE Ratio is ranked higher than
62% of the 13 Companies
in the Global Medical Distribution industry.

( Industry Median: 13.99 vs. PDCO: 11.05 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 8.62
PDCO's PE Ratio without NRI is ranked higher than
92% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 19.94 vs. PDCO: 8.62 )
Ranked among companies with meaningful PE Ratio without NRI only.
PDCO' s PE Ratio without NRI Range Over the Past 10 Years
Min: 8.44  Med: 19.31 Max: 33.24
Current: 8.62
8.44
33.24
PB Ratio 1.44
PDCO's PB Ratio is ranked higher than
64% of the 58 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.12 vs. PDCO: 1.44 )
Ranked among companies with meaningful PB Ratio only.
PDCO' s PB Ratio Range Over the Past 10 Years
Min: 1.41  Med: 2.85 Max: 4.53
Current: 1.44
1.41
4.53
PS Ratio 0.38
PDCO's PS Ratio is ranked higher than
69% of the 58 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.91 vs. PDCO: 0.38 )
Ranked among companies with meaningful PS Ratio only.
PDCO' s PS Ratio Range Over the Past 10 Years
Min: 0.37  Med: 1.05 Max: 1.89
Current: 0.38
0.37
1.89
Price-to-Free-Cash-Flow 11.88
PDCO's Price-to-Free-Cash-Flow is ranked higher than
68% of the 25 Companies
in the Global Medical Distribution industry.

( Industry Median: 14.20 vs. PDCO: 11.88 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
PDCO' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 9.26  Med: 19.49 Max: 1557.19
Current: 11.88
9.26
1557.19
Price-to-Operating-Cash-Flow 9.78
PDCO's Price-to-Operating-Cash-Flow is ranked higher than
61% of the 31 Companies
in the Global Medical Distribution industry.

( Industry Median: 12.02 vs. PDCO: 9.78 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
PDCO' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 8.33  Med: 16.72 Max: 275.91
Current: 9.78
8.33
275.91
EV-to-EBIT 11.33
PDCO's EV-to-EBIT is ranked higher than
62% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 14.52 vs. PDCO: 11.33 )
Ranked among companies with meaningful EV-to-EBIT only.
PDCO' s EV-to-EBIT Range Over the Past 10 Years
Min: 6.7  Med: 12.4 Max: 21.5
Current: 11.33
6.7
21.5
EV-to-EBITDA 8.73
PDCO's EV-to-EBITDA is ranked higher than
65% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.88 vs. PDCO: 8.73 )
Ranked among companies with meaningful EV-to-EBITDA only.
PDCO' s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.2  Med: 11.05 Max: 18.4
Current: 8.73
6.2
18.4
EV-to-Revenue 0.58
PDCO's EV-to-Revenue is ranked higher than
57% of the 58 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.93 vs. PDCO: 0.58 )
Ranked among companies with meaningful EV-to-Revenue only.
PDCO' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.6  Med: 1.1 Max: 1.8
Current: 0.58
0.6
1.8
PEG Ratio 3.44
PDCO's PEG Ratio is ranked lower than
68% of the 28 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.54 vs. PDCO: 3.44 )
Ranked among companies with meaningful PEG Ratio only.
PDCO' s PEG Ratio Range Over the Past 10 Years
Min: 0.9  Med: 2.49 Max: 30.2
Current: 3.44
0.9
30.2
Shiller PE Ratio 10.46
PDCO's Shiller PE Ratio is ranked higher than
81% of the 21 Companies
in the Global Medical Distribution industry.

( Industry Median: 27.63 vs. PDCO: 10.46 )
Ranked among companies with meaningful Shiller PE Ratio only.
PDCO' s Shiller PE Ratio Range Over the Past 10 Years
Min: 10.26  Med: 21.43 Max: 39.26
Current: 10.46
10.26
39.26
Current Ratio 1.80
PDCO's Current Ratio is ranked higher than
65% of the 54 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.50 vs. PDCO: 1.80 )
Ranked among companies with meaningful Current Ratio only.
PDCO' s Current Ratio Range Over the Past 10 Years
Min: 0.95  Med: 2.66 Max: 3.71
Current: 1.8
0.95
3.71
Quick Ratio 1.00
PDCO's Quick Ratio is ranked lower than
59% of the 54 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.12 vs. PDCO: 1.00 )
Ranked among companies with meaningful Quick Ratio only.
PDCO' s Quick Ratio Range Over the Past 10 Years
Min: 0.73  Med: 1.76 Max: 2.79
Current: 1
0.73
2.79
Days Inventory 68.37
PDCO's Days Inventory is ranked lower than
73% of the 55 Companies
in the Global Medical Distribution industry.

( Industry Median: 41.27 vs. PDCO: 68.37 )
Ranked among companies with meaningful Days Inventory only.
PDCO' s Days Inventory Range Over the Past 10 Years
Min: 47.47  Med: 50.61 Max: 60.98
Current: 68.37
47.47
60.98
Days Sales Outstanding 57.20
PDCO's Days Sales Outstanding is ranked higher than
59% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 60.84 vs. PDCO: 57.20 )
Ranked among companies with meaningful Days Sales Outstanding only.
PDCO' s Days Sales Outstanding Range Over the Past 10 Years
Min: 44.31  Med: 51.05 Max: 61.86
Current: 57.2
44.31
61.86
Days Payable 56.04
PDCO's Days Payable is ranked lower than
63% of the 46 Companies
in the Global Medical Distribution industry.

( Industry Median: 62.55 vs. PDCO: 56.04 )
Ranked among companies with meaningful Days Payable only.
PDCO' s Days Payable Range Over the Past 10 Years
Min: 31.98  Med: 36.67 Max: 52.46
Current: 56.04
31.98
52.46

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 4.66
PDCO's Dividend Yield % is ranked higher than
81% of the 68 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.59 vs. PDCO: 4.66 )
Ranked among companies with meaningful Dividend Yield % only.
PDCO' s Dividend Yield % Range Over the Past 10 Years
Min: 0.31  Med: 1.6 Max: 4.76
Current: 4.66
0.31
4.76
Dividend Payout Ratio 0.40
PDCO's Dividend Payout Ratio is ranked lower than
51% of the 45 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.28 vs. PDCO: 0.40 )
Ranked among companies with meaningful Dividend Payout Ratio only.
PDCO' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.06  Med: 0.34 Max: 0.54
Current: 0.4
0.06
0.54
3-Year Dividend Growth Rate 13.00
PDCO's 3-Year Dividend Growth Rate is ranked higher than
54% of the 28 Companies
in the Global Medical Distribution industry.

( Industry Median: 12.70 vs. PDCO: 13.00 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
PDCO' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0  Med: 0 Max: 79.7
Current: 13
0
79.7
Forward Dividend Yield % 4.66
PDCO's Forward Dividend Yield % is ranked higher than
81% of the 69 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.45 vs. PDCO: 4.66 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 9.29
PDCO's 5-Year Yield-on-Cost % is ranked higher than
83% of the 71 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.97 vs. PDCO: 9.29 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
PDCO' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.62  Med: 3.2 Max: 9.53
Current: 9.29
0.62
9.53
3-Year Average Share Buyback Ratio 2.40
PDCO's 3-Year Average Share Buyback Ratio is ranked higher than
90% of the 41 Companies
in the Global Medical Distribution industry.

( Industry Median: -1.90 vs. PDCO: 2.40 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
PDCO' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -8.2  Med: 0.05 Max: 7.3
Current: 2.4
-8.2
7.3

Valuation & Return

vs
industry
vs
history
Price-to-Tangible-Book 8.57
PDCO's Price-to-Tangible-Book is ranked lower than
89% of the 45 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.67 vs. PDCO: 8.57 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
PDCO' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 4.23  Med: 9.53 Max: 571.08
Current: 8.57
4.23
571.08
Price-to-Intrinsic-Value-Projected-FCF 0.65
PDCO's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
88% of the 26 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.53 vs. PDCO: 0.65 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
PDCO' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.68  Med: 1.71 Max: 5.64
Current: 0.65
0.68
5.64
Price-to-Intrinsic-Value-DCF (Earnings Based) 0.81
PDCO's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked higher than
67% of the 12 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.99 vs. PDCO: 0.81 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
PDCO' s Price-to-Intrinsic-Value-DCF (Earnings Based) Range Over the Past 10 Years
Min: 0.38  Med: 1.1 Max: 3.04
Current: 0.81
0.38
3.04
Price-to-Median-PS-Value 0.36
PDCO's Price-to-Median-PS-Value is ranked higher than
86% of the 43 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.96 vs. PDCO: 0.36 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
PDCO' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.58  Med: 1.12 Max: 2.76
Current: 0.36
0.58
2.76
Price-to-Graham-Number 1.81
PDCO's Price-to-Graham-Number is ranked lower than
79% of the 29 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.45 vs. PDCO: 1.81 )
Ranked among companies with meaningful Price-to-Graham-Number only.
PDCO' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 1.95  Med: 3.01 Max: 27.09
Current: 1.81
1.95
27.09
Earnings Yield (Greenblatt) % 8.83
PDCO's Earnings Yield (Greenblatt) % is ranked higher than
69% of the 59 Companies
in the Global Medical Distribution industry.

( Industry Median: 6.16 vs. PDCO: 8.83 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
PDCO' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 4.7  Med: 8 Max: 14.9
Current: 8.83
4.7
14.9
Forward Rate of Return (Yacktman) % 8.81
PDCO's Forward Rate of Return (Yacktman) % is ranked lower than
59% of the 34 Companies
in the Global Medical Distribution industry.

( Industry Median: 12.37 vs. PDCO: 8.81 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
PDCO' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 3.1  Med: 11.3 Max: 21.9
Current: 8.81
3.1
21.9

More Statistics

Revenue (TTM) (Mil) $5,510.11
EPS (TTM) $ 2.59
Beta1.12
Volatility32.03%
52-Week Range $21.09 - 48.30
Shares Outstanding (Mil)94.63

Analyst Estimate

Apr18 Apr19 Apr20 Apr21
Revenue (Mil $) 5,576 5,777 5,959 6,144
EBIT (Mil $) 333 350 374
EBITDA (Mil $) 393 417 442 448
EPS ($) 2.21 2.44 2.59 3.05
EPS without NRI ($) 2.21 2.44 2.59 3.05
EPS Growth Rate
(Future 3Y To 5Y Estimate)
9.04%
Dividends per Share ($) 1.06 1.13 1.33

Piotroski F-Score Details

Piotroski F-Score: 55
Positive ROAY
Positive CFROAY
Higher ROA yoyY
CFROA > ROAN
Lower Leverage yoyY
Higher Current Ratio yoyN
Less Shares Outstanding yoyY
Higher Gross Margin yoyN
Higher Asset Turnover yoyN

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}